Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.

de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML, Nordenskjöld M, van der Luijt RB, Valk GD.

Eur J Endocrinol. 2012 Aug;167(2):181-7. doi: 10.1530/EJE-12-0210. Epub 2012 May 11.

2.

Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.

Pieterman CR, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, Hermus AR, Borel Rinkes IH, Vriens MR, Valk GD; DutchMEN1 Study Group..

Ann Surg. 2012 Jun;255(6):1171-8. doi: 10.1097/SLA.0b013e31824c5145.

PMID:
22470073
3.

The additional value of intraoperative parathyroid hormone assessment is marginal in patients with nonfamilial primary hyperparathyroidism: a prospective cohort study.

Twigt BA, van Dalen T, Vollebregt AM, Kortlandt W, Vriens MR, Borel Rinkes IH.

Am J Surg. 2012 Jul;204(1):1-6. doi: 10.1016/j.amjsurg.2011.07.017. Epub 2011 Dec 21.

PMID:
22192616
4.

The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.

Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD, Rinkes IH.

World J Surg. 2011 Sep;35(9):1993-2005. doi: 10.1007/s00268-011-1068-9. Review.

PMID:
21713580
5.

Shifting incidence of solitary adenomas in the era of minimally invasive parathyroidectomy. A multi-institutional study.

Twigt BA, Vollebregt AM, van Dalen T, Smits AB, Consten EC, van Vroonhoven TJ, Vriens MR, Borel Rinkes IH.

Ann Surg Oncol. 2011 Apr;18(4):1041-6. doi: 10.1245/s10434-010-1394-4. Epub 2010 Dec 21.

PMID:
21174159
6.

Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.

Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel Rinkes IH.

Endocr Pract. 2011 Jan-Feb;17(1):7-15. doi: 10.4158/EP10050.OR. Review.

PMID:
20570815
7.

Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.

Lourenço DM Jr, Coutinho FL, Toledo RA, Montenegro FL, Correia-Deur JE, Toledo SP.

J Bone Miner Res. 2010 Nov;25(11):2382-91. doi: 10.1002/jbmr.125.

8.

Normocalcemic primary hyperparathyroidism.

Bilezikian JP, Silverberg SJ.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):106-9. Review.

9.

Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy.

Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W.

Langenbecks Arch Surg. 2009 Sep;394(5):843-9. doi: 10.1007/s00423-009-0510-z. Epub 2009 Jun 16.

PMID:
19529957
10.

Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.

Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D'Agruma L, Minisola S, Corbetta S, Cole DE, Spada A, Scillitani A.

J Bone Miner Res. 2009 Aug;24(8):1404-10. doi: 10.1359/jbmr.090304.

11.

Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?

Tonelli F, Marcucci T, Fratini G, Tommasi MS, Falchetti A, Brandi ML.

Ann Surg. 2007 Dec;246(6):1075-82.

PMID:
18043113
12.

Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.

Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B.

Clin Endocrinol (Oxf). 2007 Jun;66(6):878-85. Epub 2007 Apr 15.

PMID:
17437518
13.

Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy?

Gil-Cárdenas A, Gamino R, Reza A, Pantoja JP, Herrera MF.

J Am Coll Surg. 2007 Feb;204(2):286-90. Epub 2006 Dec 18.

PMID:
17254933
14.

Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring.

Pang T, Stalberg P, Sidhu S, Sywak M, Wilkinson M, Reeve TS, Delbridge L.

Br J Surg. 2007 Mar;94(3):315-9.

PMID:
17205496
15.
16.

Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making?

Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L.

J Am Coll Surg. 2006 Jul;203(1):1-6. Epub 2006 May 30.

PMID:
16798481
17.
18.

Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays.

Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF.

Am J Surg. 2006 Jan;191(1):52-6.

PMID:
16399106
19.

Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates.

Lee CH, Tseng LM, Chen JY, Hsiao HY, Yang AH.

Ann Surg Oncol. 2006 Jan;13(1):103-9. Epub 2006 Jan 1.

PMID:
16378158
20.

Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy.

Chen H, Pruhs Z, Starling JR, Mack E.

Surgery. 2005 Oct;138(4):583-7; discussion 587-90.

PMID:
16269285

Supplemental Content

Support Center